FC

Finepoint Capital Portfolio holdings

AUM $504M
1-Year Est. Return 3.16%
This Quarter Est. Return
1 Year Est. Return
-3.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$262M
AUM Growth
-$47.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$2.36M
2
+$2.16M
3
+$2.1M
4
ARVN icon
Arvinas
ARVN
+$1.71M
5
SLDB icon
Solid Biosciences
SLDB
+$1.28M

Top Sells

1
+$20.4M
2
+$9.88M
3
+$4.9M
4
TVTX icon
Travere Therapeutics
TVTX
+$3.4M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$3.38M

Sector Composition

1 Healthcare 99.25%
2 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$19.7M 7.52%
875,221
-151,079
2
$18.7M 7.15%
283,690
-51,200
3
$17.6M 6.72%
723,600
+16,000
4
$17.2M 6.59%
916,353
-260,477
5
$17.2M 6.56%
444,659
+54,300
6
$16.9M 6.46%
122,757
-8,700
7
$16.7M 6.39%
156,072
+22,036
8
$16.3M 6.23%
388,865
+7,100
9
$16.2M 6.19%
1,460,175
+31,700
10
$16.1M 6.14%
331,600
+8,700
11
$15.8M 6.04%
614,231
-28,769
12
$14.6M 5.56%
413,793
+11,000
13
$13.9M 5.33%
868,427
+45,682
14
$13.9M 5.32%
846,270
+131,422
15
$13.4M 5.14%
492,300
+62,700
16
$13.2M 5.03%
539,445
+22,158
17
$2.32M 0.89%
488,857
+270,295
18
$444K 0.17%
504,706
19
$219K 0.08%
690,000
20
$134K 0.05%
895,000
21
$115K 0.04%
439,666
22
$114K 0.04%
571,666
23
$114K 0.04%
612,000
24
$110K 0.04%
735,000
25
$76.3K 0.03%
+489,999
1
2